Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models
Authors:
- Hui XueHXHui Xue
- Margaret SutcliffeMSMargaret Sutcliffe
- Peter W. GoutPGPeter W. Gout
- David G. HuntsmanDHDavid G. Huntsman
- Dianne M. MillerDMDianne M. Miller
- C. Blake GilksCGC. Blake Gilks
- Y.Z. WangY.Z. Wang
- 1 January 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 96 (1) , 48-55
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Establishing efficient xenograft models of models of low-grade human prostate cancerEuropean Urology Supplements, 2003
- Ovarian tissue xenograftingEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2003
- A Human Ovarian Carcinoma Murine Xenograft Model Useful for Preclinical TrialsGynecologic Oncology, 2002
- A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancerClinical & Experimental Metastasis, 1998
- Biology of ovarian cancerCurrent Opinion in Oncology, 1997
- Transplantation of a human ovarian cystadenocarcinoma into severe combined immunodeficient (SCID) mice — formation of metastases without significant alteration of the tumour cell phenotypeInternational Journal of Experimental Pathology, 1996
- Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenograftsCancer Chemotherapy and Pharmacology, 1986
- Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatinGynecologic Oncology, 1986
- Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyCancer, 1983
- Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: Six-day subrenal capsule assayCancer, 1981